Shah Sujal's Form 4 filing
CymaBay Therapeutics, Inc. (CBAY) · filed Oct 10, 2023
- Accession no.
- 0001062993-23-019205
- Filed
- Oct 10, 2023
- Trade date
- Oct 9, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 3 derivative transactions. Open-market sales total $921.0K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Shah SujalCIK 0001588861 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 9, 2023 | Common Stock | MOption exerciseAcquired | +64,861 | $5.00 | +$324,305 | 236,162 | Direct | |
| Oct 9, 2023 | Common Stock | SSaleDisposed | −64,861 | $14.20 | −$921,026.2 | 171,301 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 9, 2023 | Common Stock | MOption exerciseDisposed | −31,034 | $0.00 | $0 | 62,072 | Direct | |
| Oct 9, 2023 | Common Stock | MOption exerciseDisposed | −12,972 | $0.00 | $0 | 25,945 | Direct | |
| Oct 9, 2023 | Common Stock | MOption exerciseDisposed | −20,855 | $0.00 | $0 | 41,711 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.